
Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma
Author(s) -
Timothy S. Fenske,
Parameswaran Hari,
Jeanette Carreras,
Mei Jie Zhang,
Rammurti T. Kamble,
Brian J. Bolwell,
Mitchell S. Cairo,
Richard E. Champlin,
Yi Bin Chen,
César O. Freytes,
Robert Peter Gale,
Gregory A. Hale,
Osman İlhan,
H. Jean Khoury,
John Lister,
Dipnarine Maharaj,
David I. Marks,
Reinhold Munker,
Andrew L. Pecora,
Philip Rowlings,
Thomas C. Shea,
Patrick J. Stiff,
Peter H. Wiernik,
Jane N. Winter,
J. Douglas Rizzo,
Koen van Besien,
Hillard M. Lazarus,
Julie M. Vose
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/2f8d-4304
Subject(s) - rituximab , diffuse large b cell lymphoma , hematopoietic stem cell transplantation , lymphoma , transplantation , stem cell , medicine , haematopoiesis , hematopoietic cell , oncology , immunology , cancer research , biology , genetics